Long COVID Syndrome
14
7
8
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (14)
Dapagliflozin for Long COVID Syndrome
A Fasting Pilot Study for Long COVID
Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID?
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
Immunoadsorption in Autoimmune Long COVID
Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism
A Study to Examine Anktiva for the Treatment of COVID-19.
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Characteristics of Long COVID-19 Syndrome
Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19
Study to Evaluate the Efficacy and Safety of Plitidepsin in Adults with Post-COVID-19 Condition (PCC)
Effectiveness of a Personalized In-home Telerehabilitation Program on Self-Care in Patients with Long COVID